Sign In
Buy EYPT
$12.34
-0.190 (-1.52%)
At Close: Jun 03, 2026
EyePoint Pharmaceuticals, Inc. (EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the presentation of positive retrospective
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates
12:45pm, Wednesday, 06'th May 2020
EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -10.00% and 7.83%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stoc
EyePoint Pharmaceuticals: Q3 Earnings Insights
12:21pm, Wednesday, 06'th May 2020
Shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) were flat in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share were up 45.00% year over year to ($0.11), wh
EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments
11:00am, Wednesday, 06'th May 2020
- Total revenues of $7.5 million and net product revenues of $4.7 million - - Cash conservation and reorganization initiatives coupled with recent financings.
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Global Macular Edema Therapeutics Market 2020 Segmentation Analysis, Key Players, Industry Share and Forecast by 2025
01:29pm, Sunday, 03'rd May 2020
May 03, 2020 (CDN Newswire via Comtex) --
A recent comprehensive study titled Global Macular Edema Therapeutics Market 2020 by Company, Regions, Type and...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
EyePoint Pharmaceuticals Announces First Quarter 2020 Financial Results Release Date and Conference Call Information
12:00pm, Wednesday, 29'th Apr 2020
WATERTOWN, Mass., April 29, 2020 -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic.
Week Ahead: 3 Big Rate Decisions, Loosening Lockdowns And Tech Earnings
12:00am, Sunday, 26'th Apr 2020
Market Overview Analysis by MarketPulse (Ed Moya) covering: XAU/USD, S&P/ASX 200, Chevron Corp, Caterpillar Inc. Read MarketPulse (Ed Moya)'s latest article on Investing.com
Short Interest in Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) Declines By 21.9%
10:42am, Monday, 20'th Apr 2020
Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 3,080,000 shares, a d
Sage slashes 53% of staff as hospitals cut inpatient stays
10:14am, Wednesday, 08'th Apr 2020
FILE — Sage launched its first product last year, for postpartum depression, which is administered by IV infusion and requires a multi-day hospital stay. But the COVID-19 outbreak has led many hospi
Sage slashes 53% of staff as hospitals cut inpatient stays
10:10am, Wednesday, 08'th Apr 2020
One of the industry’s highly watched neuroscience drugmakers is cutting more than half of its workforce as it works to revive hope for its sophomore drug candidate and weather a drop in sales.
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
11:36am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2)BELLUS Health Inc (NASDAQ: BLU)Down In The Dumps (Biote
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
12:00am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 2)
BELLUS Health Inc (NASDAQ:...
Analysts Conflicted on These Healthcare Names: Baxter International (BAX) and EyePoint Pharmaceuticals (EYPT)
05:35pm, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX) and EyePoint Pharmaceuticals (EYPT). Baxter
